News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 1825
- Sources here
- 15
- Companies here
- 23
Active search
1825 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
D23 2026: Disney Reveals What’s Next in Entertainment
The D23: The Ultimate Disney Fan Event in Anaheim showcased upcoming projects from across Disney's various studios and platforms. CEO Josh D’Amaro highlighted Disney's global connection with over four billion fans, and the event featured exclusive first looks, celebrity appearances, and major announcements for …
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Wall Street Zen has upgraded Ascendis Pharma A/S (NASDAQ:ASND) from a "hold" to a "buy" rating, aligning with a consensus "Buy" rating and an average price target of $299.24 from other analysts. The company's shares opened 0.9% higher at $248.50, and it recently reported …
Is Madison Square Garden Sports (MSGS) Pricey On Earnings And Spin Off Hopes?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Madison Square Garden Sports (MSGS) is back in focus after its August 13 earnings release, which showed fourth quarter sales of US$278.75 million and …
Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Swedish Orphan Biovitrum Stock Is Back In Focus Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after a new partnership with Innate Pharma …
Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?
Two healthcare players, Scholar Rock Holding Corporation (NASDAQ:SRRK) and Novo Nordisk A/S (NYSE:NVO), find their near-term narratives intertwined over manufacturing compliance. One is smoothly navigating a supply chain hurdle ahead of a critical drug approval, while the other just delivered a complicated financial quarter. …
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares
Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu recently sold 804 shares of the company's stock for $66,442.56, reducing his total holdings by 1.46%. This sale is part of a series of insider transactions since mid-June. Despite these sales, the company exceeded its recent quarterly …
SanDisk CEO reveals what's next after explosive 3,150% stock rally
No day is a dull one when talking about SanDisk (SNDK). We have had lots of interesting positive angles before. On Thursday, Aug. 13, SanDisk gave investors something bigger than a quarterly beat or an analyst upgrade. It gave them a long-term financial model. …
Sharemaestro market context Trend signal active 52 weeks +3017.8%Discovery Silver Corp Earnings Call Signals Aggressive Growth
Key Points Interested in Discovery Silver Corp.? Here are five stocks we like better. Record quarterly performance: Discovery Silver produced 67,300 ounces of gold, up 12% sequentially, while revenue rose 12% to $319 million. Adjusted earnings increased to $92.3 million, or $0.11 per share. …
Jim Cramer Reevaluates Novo Nordisk (NVO) as Wegovy Pill Adoption Accelerates
Shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) experienced sharp volatility following its latest quarterly results. On the August 12 episode of Mad Money, Jim Cramer pointed out the disconnect between the company's strong performance and Wall Street's initial negative knee-jerk reaction. Cramer …
Sharemaestro market context Trend signal started 52 weeks -24.4% · Next-week setup negative 40.6%Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com
Disc Medicine's COO, Jonathan Yu, sold 804 shares of the company's common stock for a total of $66,444 at an average price of $82.6425. This transaction was part of a pre-arranged trading plan, and it occurred as the stock had seen a 41% return …
Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan
Disc Medicine's COO, Yu Jonathan Yen-Wen, exercised stock options for 804 shares at $13.50 each and simultaneously sold these 804 shares at a weighted average price of $82.6425. These transactions, which generated an approximate pre-tax spread of $56,000, were conducted under a pre-arranged Rule …
MSG Sports Publicly Files Form 10 Registration Statement for Proposed Spin-Off of Rangers Business from Knicks Business
NEW YORK, August 14, 2026--(BUSINESS WIRE)--Madison Square Garden Sports Corp. (NYSE: MSGS) ("MSG Sports" or the "Company") today announced that it is continuing to make progress on the proposed spin-off of its New York Rangers business from its New York Knicks business, with the …